Science Explorer Back to mapMap
Discussion
Topic · Pathology and Forensic Medicine

Ophthalmology and Eye Disorders

Ophthalmology and Eye Disorders is a research topic within Pathology and Forensic Medicine. Science Explorer counts 30k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the pathophysiology, management, and associated conditions of Graves' ophthalmopathy, including the role of thyroid-associated ophthalmopathy, orbital fibroblasts, thyrotropin receptor antibodies, teprotumumab treatment, autoimmune mechanisms, thalamus infarction, surgical interventions for strabismus, and the involvement of the IGF-1 receptor. The research covers a wide range of topics related to the understanding and treatment of Graves' ophthalmopathy.

  • Graves' Ophthalmopathy
  • Thyroid-Associated Ophthalmopathy
  • Orbital Fibroblasts
  • Thyrotropin Receptor Antibodies
  • Teprotumumab
  • Thyroid Eye Disease
  • Autoimmunity
  • Thalamus Infarction
  • Strabismus Surgery
  • IGF-1 Receptor
Research works
30k
fractional, since 1950
In the world top 10%
3k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
0%
the tick is no change
Largest producer
United States
29% of the 10 largest, 2022-now
Ophthalmology and Eye Disorders

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Ophthalmology and Eye Disorders research?

By volume, the United States and China publish the most (869 and 580 works in 2022-now).

By volume, 2022-now

  1. 1 United States 869 works
  2. 2 China 580 works
  3. 3 India 353 works
  4. 4 Japan 223 works
  5. 5 Türkiye 192 works
  6. 6 United Kingdom 189 works
  7. 7 Germany 173 works
  8. 8 South Korea 167 works
  9. 9 Brazil 144 works
  10. 10 Italy 143 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 28.6%China: 19.1%India: 11.6%Japan: 7.3%6 others listed: 33.3%29%largest
United States869 · 28.6%China580 · 19.1%India353 · 11.6%Japan223 · 7.3%6 others listed1,009 · 33.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Ophthalmology and Eye Disorders research?

By volume in 2022-now, Capital Medical University publishes the most Ophthalmology and Eye Disorders research, followed by Harvard University and Sun Yat-sen University.

By volume, 2022-now

  1. 1 Capital Medical UniversityChina 42 works
  2. 2 Harvard UniversityUnited States 40 works
  3. 3 Sun Yat-sen UniversityChina 37 works
  4. 4 All India Institute of Medical SciencesIndia 34 works
  5. 5 University College LondonUnited Kingdom 31 works
  6. 6 Mayo ClinicUnited States 29 works
  7. 7 Johns Hopkins UniversityUnited States 27 works
  8. 8 Shanghai Jiao Tong UniversityChina 26 works
  9. 9 Nanjing Medical UniversityChina 25 works
  10. 10 L V Prasad Eye InstituteIndia 22 works

Who are the leading researchers in Ophthalmology and Eye Disorders?

The most-cited researchers publishing on Ophthalmology and Eye Disorders include Jost Bruno Jonas, Karl John Friston and John Q. Trojanowski.

  1. 1 Jost Bruno Jonas Germany 350k citations
  2. 2 Karl John Friston United Kingdom 310k citations
  3. 3 John Q. Trojanowski United States 286k citations
  4. 4 Luigi Ferrucci United States 281k citations
  5. 5 Yousef Saleh Khader Jordan 274k citations
  6. 6 Cornelia M. van Duijn Netherlands 250k citations
  7. 7 Kaj Blennow Sweden 247k citations
  8. 8 André Gerardus Uitterlinden Netherlands 246k citations
  9. 9 Isabela M. Benseñor Brazil 245k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Ophthalmology and Eye Disorders?

The most cited paper in Ophthalmology and Eye Disorders is "The International Classification of Headache Disorders: 2nd edition" (Jes Olesen, Peter James Goadsby, Tim Steiner, 2003), with 5,056 citations. Next come "The cerebellar cognitive affective syndrome" (3,258) and "2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis" (2,936).

Most cited papers
#PaperReleasedCitations
1 The International Classification of Headache Disorders: 2nd edition Jes Olesen, Peter James Goadsby, Tim Steiner · The Lancet Neurology 20 Nov 2003 5,056
2 The cerebellar cognitive affective syndrome Jeremy Dan Schmahmann · Brain Apr 1998 3,258
3 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis Douglas S. Ross, Henry B. Burch, David S. Cooper et al. · Thyroid Open access 13 Aug 2016 2,936
4 Maternal Thyroid Deficiency during Pregnancy and Subsequent Neuropsychological Development of the Child James E. Haddow, Glenn E. Palomaki, Walter C. Allan et al. · New England Journal of Medicine Open access 19 Aug 1999 2,587
5 The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide LJ Stovner, Knut Hagen, Rigmor Jensen et al. · Cephalalgia Mar 2007 2,483
All 98 most cited papers, with filters and sorting

Where is Ophthalmology and Eye Disorders research done?

The largest centres of Ophthalmology and Eye Disorders research in 2022-now are Beijing (China), Seoul (South Korea), London (United Kingdom) and Istanbul (Türkiye).

Largest cities, 2022-now

  1. 1 BeijingChina 100 works
  2. 2 SeoulSouth Korea 78 works
  3. 3 LondonUnited Kingdom 71 works
  4. 4 IstanbulTürkiye 67 works
  5. 5 ShanghaiChina 61 works
  6. 6 TokyoJapan 58 works
  7. 7 MoscowRussia 57 works
  8. 8 GuangzhouChina 51 works
  9. 9 New DelhiIndia 45 works
  10. 10 ParisFrance 43 works
See Ophthalmology and Eye Disorders on the map

Where is the best place to study Ophthalmology and Eye Disorders?

Among universities, judged by research, Nanjing Medical University, Harvard University and Shanghai Jiao Tong University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 24.15%fractional works in this field (log) →share of work in the world top 10% →Shanghai Jiao Tong U…Nanjing Medical Univ…Harvard UniversitySun Yat-sen University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Nanjing Medical UniversityChina 66.726.9%7.2×25 +64.6%
2Harvard UniversityUnited States 64.922.7%3.3×40 -10.4%
3Shanghai Jiao Tong UniversityChina 63.335.9%2.3×26 +4.8%
4Sun Yat-sen UniversityChina 62.718.9%4.7×37 +26.9%
5Capital Medical UniversityChina 61.513.4%10.3×42 +17.6%
6University College LondonUnited Kingdom 61.210.0%5.0×31 +32.9%
7Chinese University of Hong KongChina 60.027.8%4.4×12 +105.4%
8Johannes Gutenberg University MainzGermany 60.041.3%7.0×10 -5.9%
9Johns Hopkins UniversityUnited States 53.116.4%4.6×27 -17.2%
10Central South UniversityChina 50.028.2%2.0×15 +61.4%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Ophthalmology and Eye Disorders, country by country

Is Ophthalmology and Eye Disorders research growing?

Output in 2022-2025 was 0% lower than in 2018-2021, peaking in 2021.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Ophthalmology and Eye Disorders as a percentage of every work published that year, 0.019% in 2024.

still counting0.020%0.040%0.060%Ophthalmology and Eye Disorders0.018% in 202519801990200020102020

Fractional works of Ophthalmology and Eye Disorders over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Ophthalmology and Eye Disorders10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Ophthalmology and Eye Disorders. Posts are plain text and can be reported.